Insider Transactions in Q2 2021 at Tyme Technologies, Inc. (TYME)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2021
|
Michael Demurjian > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
20,000
-0.08%
|
$20,000
$1.32 P/Share
|
|
Jun 21
2021
|
Michael Demurjian > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
20,000
-0.08%
|
$20,000
$1.26 P/Share
|
|
Jun 18
2021
|
Steve Hoffman Director |
SELL
Open market or private sale
|
Direct |
41,250
-0.17%
|
$41,250
$1.29 P/Share
|
|
Jun 17
2021
|
Steve Hoffman Director |
SELL
Open market or private sale
|
Direct |
41,250
-0.17%
|
$41,250
$1.33 P/Share
|
|
Jun 14
2021
|
Michael Demurjian > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
20,000
-0.08%
|
$20,000
$1.43 P/Share
|
|
Jun 09
2021
|
Steve Hoffman Director |
SELL
Open market or private sale
|
Direct |
41,250
-0.17%
|
$41,250
$1.58 P/Share
|
|
Jun 08
2021
|
Steve Hoffman Director |
SELL
Open market or private sale
|
Direct |
41,250
-0.17%
|
$41,250
$1.57 P/Share
|
|
Jun 07
2021
|
Michael Demurjian > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
20,000
-0.08%
|
$20,000
$1.61 P/Share
|
|
Jun 01
2021
|
Michael Demurjian > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
20,000
-0.08%
|
$20,000
$1.58 P/Share
|
|
May 27
2021
|
Steve Hoffman Director |
SELL
Open market or private sale
|
Direct |
41,250
-0.17%
|
$41,250
$1.47 P/Share
|
|
May 26
2021
|
Steve Hoffman Director |
SELL
Open market or private sale
|
Direct |
41,250
-0.17%
|
$41,250
$1.38 P/Share
|
|
May 24
2021
|
Michael Demurjian > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
20,000
-0.08%
|
$20,000
$1.35 P/Share
|
|
May 17
2021
|
Michael Demurjian > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
20,000
-0.08%
|
$20,000
$1.31 P/Share
|
|
May 12
2021
|
Steve Hoffman Director |
SELL
Open market or private sale
|
Direct |
41,250
-0.17%
|
$41,250
$1.2 P/Share
|
|
May 11
2021
|
Steve Hoffman Director |
SELL
Open market or private sale
|
Direct |
41,250
-0.17%
|
$41,250
$1.2 P/Share
|
|
May 11
2021
|
Michael Demurjian > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
20,000
-0.08%
|
$20,000
$1.23 P/Share
|
|
May 03
2021
|
Michael Demurjian > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
20,000
-0.08%
|
$20,000
$1.5 P/Share
|
|
Apr 28
2021
|
Steve Hoffman Director |
SELL
Open market or private sale
|
Direct |
41,750
-0.17%
|
$41,750
$1.57 P/Share
|
|
Apr 27
2021
|
Steve Hoffman Director |
SELL
Open market or private sale
|
Direct |
41,750
-0.17%
|
$41,750
$1.56 P/Share
|
|
Apr 26
2021
|
Michael Demurjian > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
20,000
-0.08%
|
$20,000
$1.54 P/Share
|
|
Apr 19
2021
|
Michael Demurjian > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
20,000
-0.08%
|
$20,000
$1.45 P/Share
|
|
Apr 14
2021
|
Steve Hoffman Director |
SELL
Open market or private sale
|
Direct |
41,750
-0.17%
|
$41,750
$1.56 P/Share
|
|
Apr 13
2021
|
Steve Hoffman Director |
SELL
Open market or private sale
|
Direct |
41,750
-0.17%
|
$41,750
$1.51 P/Share
|
|
Apr 12
2021
|
Michael Demurjian > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
20,000
-0.08%
|
$20,000
$1.57 P/Share
|
|
Apr 07
2021
|
Jan M Van Tornout Acting Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
247
+12.01%
|
$247
$1.7 P/Share
|
|
Apr 06
2021
|
Jan M Van Tornout Acting Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
245
+13.56%
|
$245
$1.69 P/Share
|
|
Apr 05
2021
|
Jan M Van Tornout Acting Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
1,317
+50.0%
|
$1,317
$1.85 P/Share
|
|
Apr 05
2021
|
Michael Demurjian > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
20,000
-0.08%
|
$20,000
$1.78 P/Share
|